Nothing new in the forum from what I heard. Except going to be very difficult to get, if not impossible, to the interim AD analysis without another CR. Reckon all is hanging out on the XanaCIDD result IMO! Again they have underestimated the cash requirements especially if the retail participation is not flattering.
Ann: ACW March 2024 quarterly activity report & Appendix 4C, page-36
Add ACW (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
2.6¢ |
Change
0.000(0.00%) |
Mkt cap ! $76.57M | |||
| Open | High | Low | Value | Volume |
| 2.6¢ | 2.7¢ | 2.5¢ | $151.1K | 5.814M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 14 | 2007355 | 2.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.6¢ | 396794 | 2 |
View Market Depth
| Last trade - 16.10pm 02/10/2024 (20 minute delay) ? |
| ACW (ASX) Chart |